BioPharma Engineering Conference Life Sciences Pharma Project Management White Paper Life Sciences

Pharma Project Management – “How to Achieve Good Governance”

In 2016, the FDA approved less than 50% of the drugs from the previous year. Why?

This Pharma Project Management White Paper explores the reasoning behind this and explains the latest cost models involved in bringing a drug from discovery to the patient. We chronicle the overall challenges that pharmaceutical companies face today before describing some specific project management challenges. We highlight the function of an EPMO (Enterprise Project Management Office) and how it enables organizations to respond quickly to changes by establishing techniques and processes that provide visibility standardization, measurement, and process improvement. PPM (portfolio project management) software allows project managers and senior management to more efficiently bring new pharmaceutical products to market, from discovery to R&D to marketing, providing insight, control, and competitive edge.

Extract:

“Even though technology has changed the Pharmaceutical landscape forever, the scientific processes and methodologies are still understandably thoughtful, deliberate, and oftentimes slow. Speeding up research projects has dangerous consequences. Making scientists accountable for success-driven projects is also fraught with danger. On average, it takes at least ten years for a new medicine to complete the journey from initial discovery to the marketplace, with clinical trials alone taking six to seven years on average. How do we, or should we increase scientific productivity? Pharma’s output level has remained more or less at a stable level for the past decade. And there is little reason to believe that this productivity will suddenly increase any time soon. Precision or personalized medicine, to get the right patient the right treatment at the right dose, the first time can potentially be addressed by technological advancements. The harsh reality is that through increased consumer demand, shorter research and development lifecycles, and cut-throat competition, the pharmaceutical industry is moving faster than ever. Some would argue that pharmaceutical companies suffer from a legacy of “the old guard” style of management where the cultural environment can feel similar to the public sector. Massive organizations need to change and change fast if they are to survive. ​”

Share this:

Share on linkedin
Share on twitter
Share on email
Share on whatsapp
Share on facebook
Share on print

Latest News

Connect with Cora

Keep up to date with company and industry news via your preferred App